11-12 May 2017:
Defymed will be present at the JDRF Encapsulation Consortium that will be held in New York – USA. Defymed will present the latest results on MailPan ®’s Bioartificial Pancreas development. This privileged group gathers worldwide key opinion leaders in the field of Cell therapy and Encapsulation for the treatment of Type1 Diabetes.
For more info.